MONday, DECEMBER 4, 2017, 11 AM
"Armored Chimeric Antigen Receptor (CAR) T Cells for Solid Tumor Malignancies"
Oladapo Yeku, MD, PhD
Medical Oncology Fellow, Memorial Sloan Kettering Cancer Center
THURSday, NOVEMber 30, 2017, 11 AM
"Type 1 Interferons Promote Alloimmune Responses to Transfused RBC Antigens"
David Gibbs, MD, PhD
Transfusion Medicine/Blood Bank Fellow, Department of Laboratory Medicine, Yale University
TueSday, NOVEMber 28, 2017, 11 AM
"Stem Cell-Derived Megakaryocytes Tool for Translational Research and Source of Cellular Therapies"
Camelia Iancu-Rubin, PhD
Associate Professor, Scientific Director, Hematological Malignancies Tissue Bank, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
monday, NOVEMber 20, 2017, 11 AM
"Investigations into the AML Cell Surfaceome"
Senior Research Scientist, Memorial Sloan Kettering Cancer Center, New York
THURSday, NOVEMber 16, 2017, 11 AM
"Insights into Immune Defects in Rag-deficiency and Stem Cell Collections for Gene Therapy in Sickle Cell Anemia"
THURSday, october 12, 2017, 11 AM
"Heterogeneity Assays and Platelet Lysate: Challenges and Chances for Stem Cell Therapies Development"
THURSday, SEPTEMBER 7, 2017, 11 AM
"Exploring the Human Microbiome"Tao Ding, PhD
monday, AUGUST 21, 2017, 11 AM
"Inflammasomes and Danger Signals during Infection by Intracellular Pathogens"
Professor and Chair, Department of Biomedical Sciences, University of the Pacific, Arthur A. Dugoni School of Dentistry
monday, july 24, 2017, 2 pM
"Inflammatory Modulation of the Bone Marrow Hematopoietic Niche"
Leslie E. Silberstein, MD
Director, Joint Program in Transfusion Medicine, Professor, Harvard Medical School
THURSday, july 20, 2017, 11 AM
"Dickkopf-1: The Wnt Antagonist Becomes a Novel Immunomodulator"
Wook-Jin Chae, PhD
Associate Research Scientist, Department of Immunobiology, Yale University School of Medicine
monday, july 17, 2017, 1 pm
“Making Platelets In Vitro from Pluripotent Stem Cells: Going Beyond Transfusion and Blood Clotting”
Cedric Ghevaert, MD, PhD
Consultant Hematologist, Senior Lecturer in Transfusion Medicine, Department of Hematology, University of Cambridge, UK
thursday, may 18, 2017, 11 am
“The Mechanism of Action of Anti-D in Preventing Hemolytic Disease of the Fetus and Newborn: What Do We Really Know?”
Alan H. Lazarus, PhD
Scientist, St. Michael's Hospital and Canadian Blood Services, Professor of Medicine, University of Toronto
wednesday, april 5, 2017, 1 pm
“Genetics and Metabolomics of Blood Storage”
James C. Zimring, MD, PhD
Director and Chief Scientific Officer, BloodworksNW Research Institute, Professor, Department of Lab Medicine and Department of Medicine, University of Washington School of Medicine
thursday, march 2, 2017, 11 am
“Insights into ZIKV Epidemiology, Diagnostics and Pathogenesis from Studies of Blood Donors and Recipients”
Michael Busch, MD, PhD
Director and VP, Research and Scientific Affairs, Blood Systems Research Institute
thursday, february 16, 2017, 11 am
“Engineering of Complex Tissues - New Possibilities for Drug Development and Regenerative Medicine”
Jan Hansmann, PhD
Group Leader, University Hospital of Würzburg, Fraunhofer Institute of Interfacial Engineering and Biotechnology
Tuesday, January 3, 2016
"The Role of Heme and Iron in Vascular Dysfunction and Inflammation: Lesson from Iron Overload Disorders”
Francesca Vinchi, PhD
Heidelberg University Hospital & EMBL
Friday, December 16, 2016
“Predictive Modeling of Infectious Disease Severity in Animals and Human Cohorts Using a Systems Biology Approach”
Elodie Ghedin, PhD
New York University
"What Happens When Nucleated Cells are Killed by Complement? Explorations in Four-Color Movies"
Robert P. Taylor, PhD
University of Virginia Health Science Center
Want more information?